GlassScriptPhysician profile
Fateh Uddin Ahmed
NPI 1306844956
$48,784.68
in general payments reported to CMS, 2019-2025
53 companies · $4,176 in 2025
The $4,176 reported for 2025 was more than what 86% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,767 · 2020: $7,914 · 2021: $16K · 2022: $6,034 · 2023: $3,940 · 2024: $3,284 · 2025: $4,176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,656.70 |
| Education | $743.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $29,766.04 | 2019-2025 | Tezspire, Airsupra, Fasenra |
| Glaxosmithkline, LLC. | $2,209.55 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,819.09 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Jazz Pharmaceuticals INC. | $1,563.11 | 2019-2025 | |
| United Therapeutics Corporation | $1,458.75 | 2019-2025 | Tyvaso, Tyvaso, Orenitram |
| Axsome Therapeutics, INC. | $1,149.33 | 2022-2025 | Sunosi |
| Harmony Biosciences LLC | $1,109.99 | 2020-2025 | Wakix |
| Baxter Healthcare | $938.31 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Regeneron Healthcare Solutions, INC. | $927.06 | 2019-2025 | Dupixent |
| Mylan Specialty L.P. | $914.44 | 2019-2024 | Yupelri |
| Genzyme Corporation | $896.21 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $738.66 | 2020-2025 | Glassia |
| Grifols USA, LLC | $703.52 | 2019-2025 | Prolastin-C Liquid |
| Actelion Pharmaceuticals US, INC. | $447.91 | 2019-2024 | Opsumit, Uptravi |
| Amgen INC. | $425.03 | 2022-2025 | Tezspire, Tavneos |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $309.86 | 2021-2025 | Arikayce, Brinsupri |
| Avadel Cns Pharmaceuticals, LLC | $302.08 | 2023-2025 | Lumryz |
| Genentech USA, INC. | $265.35 | 2019-2023 | Esbriet, Xolair |
| Sunovion Pharmaceuticals INC. | $263.32 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $225.56 | 2019-2023 | |
| Pulmonx Corporation | $179.71 | 2021-2024 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Electromed, INC. | $177.38 | 2019-2025 | Smartvest |
| Astellas Pharma US INC | $163.88 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $155.98 | 2022-2023 | |
| Inspire Medical Systems, INC. | $154.59 | 2021-2025 | Inspire |
| Advanced Respiratory, INC | $152.13 | 2019-2021 | |
| Pfizer INC. | $149.01 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2020 | |
| Janssen Pharmaceuticals, INC | $109.34 | 2021-2022 | |
| Viatris Specialty LLC | $102.75 | 2025 | Yupelri |
| Philips North America LLC | $95.05 | 2019-2025 | Vest Therapy Und |
| Inogen, INC. | $93.69 | 2022-2025 | Inogen |
| Paratek Pharmaceuticals, INC. | $65.45 | 2021 | |
| Mallinckrodt Hospital Products INC. | $56.71 | 2021 | |
| Csl Behring | $54.60 | 2020 | |
| Circassia INC. | $53.82 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $47.79 | 2019-2020 | |
| Ani Pharmaceuticals, INC. | $39.77 | 2024-2025 | Purified Cortrophin Gel |
| Phadia US INC. | $35.07 | 2023 | Immunocap |
| Eisai INC. | $34.81 | 2021 | |
| Shire North American Group INC | $34.03 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $33.07 | 2021 | |
| Verona Pharma, INC. | $32.92 | 2025 | Ohtuvayre |
| Idorsia Pharmaceuticals US INC | $32.66 | 2022-2023 | Quviviq |
| Mayne Pharma Commercial LLC | $30.28 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $28.22 | 2021-2023 | Eliquis |
| Mallinckrodt Enterprises LLC | $23.35 | 2019 | |
| Arbor Pharmaceuticals, INC. | $18.91 | 2021 | |
| Novartis Pharmaceuticals Corporation | $16.33 | 2023 | |
| Fisher & Paykel Healthcare INC | $15.69 | 2019 | |
| Lilly USA, LLC | $14.30 | 2025 | Zepbound |
| Allergan, INC. | $12.99 | 2020 | |
| Covis Pharma Gmbh | $12.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fateh Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.